Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DoximityBSP:D2OC34 +36.02%64 3-Year ROIIC % is 98.98 as of Mar. 2026, which is 72% above its 10-year median of 57.56. GuruFocus rates BSP:D2OC34 with a GF Score™ of 64/100 and a GF Value™ of R$39.54 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 619 Healthcare Providers & Services companies, Doximity ranks better than 89.82% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Doximity's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 98.98%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Doximity's 3-Year ROIIC % or its related term are showing as below:
BSP:D2OC34's 3-Year ROIIC % is ranked better than 89.82% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.48
vs BSP:D2OC34: 98.98
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Doximity 3-Year ROIIC % Related Terms
Doximity 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Doximity's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:D2OC34 vs PRVA, WAY, HTFL: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, Doximity's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Doximity 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Doximity's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Doximity's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Doximity (BSP:D2OC34) has a 3-Year ROIIC % of 98.98 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Doximity and its competitors. This is 72% above median its historical median of 57.56. Over the past decade, Doximity's 3-Year ROIIC % has ranged from 38.48 to 98.98. According to the industry distribution chart, Doximity ranks #63 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 10.2%.
Is Doximity's 3-Year ROIIC % too high?
Doximity's current 3-Year ROIIC % of 98.98 is 72% above median its 10-year median of 57.56. Over the past 10 years, this metric has ranged from a low of 38.48 to a high of 98.98. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.48. Doximity's value of 98.98 is 2744.3% above this industry median. Based on the distribution chart, Doximity ranks #63 out of 619 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Doximity has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's 3-Year ROIIC % compare to PRVA and WAY?
According to the Healthcare Providers & Services industry distribution chart, Doximity ranks #63 out of 619 companies for 3-Year ROIIC %. This places Doximity in the top 10% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.48. Doximity's value of 98.98 is 2744.3% above this benchmark. Historically, Doximity's own 3-Year ROIIC % has ranged from 38.48 to 98.98 over the past decade. While the company's 10-year median is 57.56 vs. the industry median of 3.48, Doximity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.48, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Doximity's current 3-Year ROIIC % of 98.98 is 2744.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Doximity and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Doximity's current 3-Year ROIIC % is 98.98, which is 72% above median its own 10-year median of 57.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (BSP:D2OC34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$39.54, compared to a current price of R$23.94 — trading 39.5% below its estimated fair value. The current 3-Year ROIIC % is 98.98, which is 72% above median its 10-year median of 57.56 and 2744.3% above the Healthcare Providers & Services industry median of 3.48. Doximity's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Doximity (BSP:D2OC34), the current 3-Year ROIIC % is 98.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Doximity (BSP:D2OC34) Overvalued in 2026?
Based on GuruFocus' analysis, Doximity stock appears to be undervalued.
The current stock price of R$23.94 is trading 39.5% below its estimated GF Value™ of R$39.54.
GuruFocus considers Doximity to be Significantly Undervalued.
Key valuation signals for BSP:D2OC34:
3-Year ROIIC %: 98.98 (72% above median its 10-year median of 57.56)
GF Value™: R$39.54 vs. price of R$23.94 (39.5% below fair value)
Industry Position: 2744.3% above the Healthcare Providers & Services median (#63 of 619)
No single metric tells the full story. See the BSP:D2OC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
64GF Score
Get the complete analysis for BSP:D2OC34
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:D2OC34 has been successfully added to your 
